EMERALD HEALTH SCIENCES INC.10 percent owner10 percent owner
Warrants with Credit Facility of Oct 5, 2018
2,500,000
$0.04
$97,500
Purchase
DHILLON PUNITdirector, officer: CEOdirector, officer: CEO
Employee Option Grant (Right to Buy)
1,000,000
$0.05
$45,000
Purchase
HEPPELL JAMES Ldirectordirector
Director Option Grant (Right to Buy)
500,000
$0.05
$22,500
Sale
EMERALD HEALTH SCIENCES INC.
Common Stock
3,000,000
N/A
N/A
Sale
EMERALD HEALTH SCIENCES INC.
Common Stock
2,566,666
$0.1
$256,667
Purchase
EMERALD HEALTH SCIENCES INC.10 percent owner10 percent owner
Common Stock Warrants (right to buy)
20,400,000
$0.1
$2,040,000
Purchase
EMERALD HEALTH SCIENCES INC.10 percent owner10 percent owner
Common Stock
15,000,000
N/A
N/A
Purchase
MCLAUGHLIN GERALD W.
Series A Preferred Stock
10,000
N/A
N/A
Purchase
MCLAUGHLIN GERALD W.
Common Stock Warrant (Right to Buy)
2,000
N/A
N/A
Sale
LADIN BRIAN D
Common Stock
11,830
N/A
N/A
Sale
LADIN BRIAN D
Common Stock
23,000
N/A
N/A
Sale
LADIN BRIAN D
Common Stock
15,800
N/A
N/A
Showing 1 to 36 of 36 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.
